January 11th 2024
Variations and conditions included in existing state bills, however, limit the effectiveness of this approach.
Risks and Liabilities in Pharmacy Practice
1.0 Credit / Law
View More
Navigating Approved Pre-exposure Prophylaxis (PrEP) Options for HIV Prevention: The Expanding Role of Pharmacists as Patient Educators and Advocates (Pharmacist Credit)
2.0 Credits / HIV/AIDS
View More
Navigating Approved Pre-exposure Prophylaxis (PrEP) Options for HIV Prevention: The Expanding Role of Pharmacists as Patient Educators and Advocates (Pharmacy Technician Credi...
2.0 Credits / HIV/AIDS
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Prior Authorizations Pose Barrier to Access for HIV Preexposure Prophylaxis
November 27th 2023The study authors reported that plans in the South had the highest rates of exclusive PAs for either emtricitabine/tenofovir disoproxil fumarate or emtricitabine/tenofovir alafenamide even if the plan covered both, from 2018 to 2020.
Read More
Lenacapavir Demonstrates Small Margin of Resistance for Those Heavily Treated With HIV
October 25th 2023Patients with HIV who were resistant to treatment with lenacapavir (Sunlenca; Gilead Sciences Inc) were found to have inadequate adherence to optimized background regimen or did not have a fully active antiretroviral.
Read More
Study Finds PrEP Boosts Confidence of Having HIV Transmission-Free Sex Among At-Risk Populations
October 11th 2023Pre-exposure prophylaxis found to provide peace of mind for patients at risk of HIV, and coupled with frequent HIV testing in the health care setting, lowers the perceived risk of contracting the disease.
Read More
Report: Gen Z Knows Least About HIV Compared to Older Generations
September 20th 2023Investigators of the GLAAD and Gilead COMPASS Initiative survey tracked the progress against HIV stigma, the transmission and prevention of HIV, and the attitudes and knowledge of those living with HIV in the United States.
Read More
Study: Blood Cancer Treatment Found to Kill Latent HIV-Infected Cells, Possible New Treatment
September 6th 2023Although antiretroviral therapies are the standard of care treatment for those with HIV, the drugs cannot target latent infections; however, venetoclax, a blood cancer treatment, shows promise.
Read More
PrEP Services in Pharmacies Across Southeastern US Would Increase Treatment Capacity for HIV
August 1st 2023A new study revealed multiple locations across the southeast, including Georgia, Kentucky, and Florida, with areas that had high HIV risk but little-to-no preexposure prophylaxis services in the area.
Read More
Twice-Yearly Subcutaneous Lenacapavir Injection for HIV Provides Favorable Quality-of-Life Outcomes
July 27th 2023Further analysis shows that 300 mg lenacapvir tablets plus an optimized background regimen can effectively reconcile a missed dose of lenacapavir injection in patients with HIV.
Read More
New Model Risk Factors for HIV in Women Include Pregnancy, Hepatitis C, and Substance Use
June 23rd 2023Model produces information that can lead to individual providers identifying women who may need more targeted and more frequent HIV testing or be good candidates for preexposure prophylaxis.
Read More